Why the study?
Does a minimal-invasive metabolic test detect malignant hyperthermia susceptibility in a patient after a sevoflurane-induced metabolic crisis?
Does a minimal-invasive metabolic test detect malignant hyperthermia susceptibility in a patient after a sevoflurane-induced metabolic crisis?
A novel minimal-invasive metabolic test may serve as an alternative to invasive in vitro contracture testing for confirming malignant hyperthermia susceptibility.
May support minimal-invasive testing after sevoflurane crisis; leaves open replacement of invasive contracture testing.
Malignant hyperthermia is a rare but life-threatening complication of general anesthesia in predisposed patients usually triggered by potent inhalation anesthetics and/or the depolarizing muscle relaxant succinylcholine. The authors present a case of delayed sevoflurane-induced malignant hyperthermia in a 21-year-old male patient that was sufficiently treated by discontinuation of trigger agent application and dantrolene infusion. After surviving an MH episode diagnostic procedures are indicated to increase patient safety. In the presented case, the use of a novel minimal-invasive metabolic test with intramuscular injection of halothane and caffeine successfully confirmed MH susceptibility and hence might be an alternative for invasive in vitro contracture testing in selected cases.
No takes yet. Share an insight, caveat, or question.
Schuster et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: